Oorsprong van het eerstegraads netwerk van Florence Gardette
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Bio Jag SAS
 Bio Jag SAS Investment ManagersFinance Bio Jag SAS provide investment services. The company was founded in December 11, 2006 and is headquartered in Clermont-Ferrand, France.
1
| Subsidiary | Investment Managers | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Florence Gardette via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BIOCORP | Medical Specialties | Chief Executive Officer | |
| Bio V.A.A SAS | Chairman | ||
| Family Immobilier SAS | Chairman | ||
| Jade CE SAS | Chairman | ||
| Brenus Développement SAS | Chairman | ||
Brenus Menuiseries SARL
 Brenus Menuiseries SARL Engineering & ConstructionIndustrial Services Brenus Menuiseries SARL engages in painting and glazing works. The private company is based in Villeneuve De Riviere, France. | Engineering & Construction | Corporate Officer/Principal | |
Gilet Aluminium SARL
 Gilet Aluminium SARL Wholesale DistributorsDistribution Services Gilet Aluminium SARL is a French company that wholesales wood and building materials. The private company is based in Montayral, France. | Wholesale Distributors | Corporate Officer/Principal | |
CFL BIOTECH SAS
 CFL BIOTECH SAS Miscellaneous Commercial ServicesCommercial Services CFL BIOTECH SAS is a French company that specializes in researching and developing biotechnology. The private company is based in Issoire, France. | Miscellaneous Commercial Services | Chairman | |
| Realty France 1 SCI | Corporate Officer/Principal | ||
Brenus Pharma SAS
 Brenus Pharma SAS Miscellaneous Commercial ServicesCommercial Services Brenus Pharma SAS is a French company that has developed an allogeneic platform to generate first in class immune therapy to prevent cancer resistance over treatment. The company is based in Issoire, France. The company's technology, stc10-10, targets mss and msi-h population with a robust and validated preclinical data pack to offer an off-the-shelf technology allowing control of both time and cost of the manufacturing process. Brenus Pharma aims to harness a specific, highly potent, and durable immune response against moving targets in cancer by claiming the representativity, the antigenicity, and the immunogenicity of its solution. The company was founded by Benoit Pinteur, Jacques Gardette. The CEO is Paul Bravetti. | Miscellaneous Commercial Services | Founder |
Statistieken
Internationaal
| Frankrijk | 11 |
Sectoraal
| Commercial Services | 3 |
| Health Technology | 2 |
| Industrial Services | 2 |
| Distribution Services | 2 |
Operationeel
| Chairman | 7 |
| Founder | 3 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
| Investor Relations Contact | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Jacques Gardette | 11 |
- Beurs
- Insiders
- Florence Gardette
- Bedrijfsconnecties
